| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/20/2011 | WO2011008572A2 5-ht3 receptor modulators, methods of making, and use thereof |
| 01/20/2011 | WO2011008298A2 Novel axomadol dosage forms |
| 01/20/2011 | WO2011008274A2 Reduced volume formulation of glatiramer acetate and methods of administration |
| 01/20/2011 | WO2011007899A1 Glycine transporter inhibitors |
| 01/20/2011 | WO2011007819A1 Pharmaceutical product containing lactam or benzene sulfonamide compound |
| 01/20/2011 | WO2011007794A1 Zeolite and sericite-containing composition for medical or medical assisting uses |
| 01/20/2011 | WO2011007756A1 Heterocyclic compound and use thereof |
| 01/20/2011 | WO2011007722A1 3-substituted-2-furancarboxylic acid hydrazide derivative and pharmaceutically acceptable salt thereof |
| 01/20/2011 | WO2011007320A1 Humic substances and therapeutic uses thereof |
| 01/20/2011 | WO2011007247A1 Novel carbamate amino acid and peptide prodrugs of opioids and uses thereof |
| 01/20/2011 | WO2011007091A1 Derivatives of 5,6-bisaryl-2-pyridine-carboxamide, preparation thereof, and therapeutic use thereof as urotensin-ii receptor antagonists |
| 01/20/2011 | WO2011006983A1 Amino derivatives of dihydro-1,3,5-triazine for treating oxidative stress |
| 01/20/2011 | WO2011006960A1 Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction |
| 01/20/2011 | WO2011006910A1 Imidazole derivatives as mglur5 antagonists |
| 01/20/2011 | WO2011006903A1 Substituted triazole and imidazole derivatives as gamma secretase modulators |
| 01/20/2011 | WO2011006653A1 An agent for restoring lost memory on the basis of n,n'-substituted 3,7-diazabicyclo[3.3.1] nonanes |
| 01/20/2011 | WO2011006638A1 Process for the synthesis of paliperidone |
| 01/20/2011 | WO2011006387A1 Process for preparing agomelatine, crystals of agomelatine and preparing process thereof |
| 01/20/2011 | WO2010138600A3 Pharmaceutical compositions for the treatment of pain |
| 01/20/2011 | WO2010110552A3 Composition for prevention or treatment of insomnia |
| 01/20/2011 | WO2010062656A3 Deuterated 2-propylpentanoic acid compounds |
| 01/20/2011 | US20110016538 Susceptibility locus for schizophrenia |
| 01/20/2011 | US20110015437 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 01/20/2011 | US20110015370 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 01/20/2011 | US20110015274 Form of an aminoindan mesylate derivative |
| 01/20/2011 | US20110015272 Sirtuin 1 and the Treatment of Neurodegenerative Diseases |
| 01/20/2011 | US20110015261 Use of a composition comprising at least one beta-blocker for the treatment of sleep disorders |
| 01/20/2011 | US20110015254 PTPH1 Inhibitors for the Treatment of Alzheimer's Disease |
| 01/20/2011 | US20110015240 Thiazole derivative and use thereof as vap-1 inhibitor |
| 01/20/2011 | US20110015235 Novel phenylethynyl derivatives of 8-aza-bicyclo[3.2.1]octane and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/20/2011 | US20110015231 Isoxazole and isothiazole compounds useful in the treatment of inflammation |
| 01/20/2011 | US20110015230 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same |
| 01/20/2011 | US20110015219 (+)-Morphinans as Antagonists of Toll-Like Receptor 9 and Therapeutic Uses Thereof |
| 01/20/2011 | US20110015217 Pro-Neurogenic Compounds |
| 01/20/2011 | US20110015211 Fibrosis inhibitor |
| 01/20/2011 | US20110015209 Sigma ligands for neuronal regeneration and functional recovery |
| 01/20/2011 | US20110015208 Pharmaceutical compositions containing dopamine receptor ligands and methods of treatment using dopamine receptor ligands |
| 01/20/2011 | US20110015205 Trazodone Composition for Once a Day Administration |
| 01/20/2011 | US20110015202 Imidazoles |
| 01/20/2011 | US20110015200 Nitrogen-containing bycyclic compounds active on chronic pain conditions |
| 01/20/2011 | US20110015198 Diarylmethylamide derivative having melanin-concentrating hormone receptor antagonism |
| 01/20/2011 | US20110015195 Aryl ureas with angiogenisis inhibiting activity |
| 01/20/2011 | US20110015193 1, 5-dihydro-pyrazolo (3, 4-d) pyrimidin-4-one derivatives and their use as pde9a mudulators for the treatment of cns disorders |
| 01/20/2011 | US20110015190 Gamma secretase modulators |
| 01/20/2011 | US20110015188 Treatment of Seasonal Conditions |
| 01/20/2011 | US20110015187 Substituted heteroarylamide diazepinopyrimidone derivatives |
| 01/20/2011 | US20110015186 Methods and compositions for protecting and treating neuroinjury |
| 01/20/2011 | US20110015185 Benzofuran Compounds |
| 01/20/2011 | US20110015184 Vinyl-phenyl derivatives for inflammation and immune-related uses |
| 01/20/2011 | US20110015183 Substituted pyrazole sigma receptor antagonists |
| 01/20/2011 | US20110015182 Novel carbamate amino acid and peptide prodrugs of opioids and uses thereof |
| 01/20/2011 | US20110015179 Compositions for treating cognitive disorders |
| 01/20/2011 | US20110015178 Amido-Thiophene Compounds and Their Use |
| 01/20/2011 | US20110015177 Substituted arylamide oxazepinopyrimidone derivatives |
| 01/20/2011 | US20110015176 Substituted heteroarylamide oxazepinopyrimidone derivatives |
| 01/20/2011 | US20110015175 Bicyclic Compounds for the Reduction of Beta-Amyloid Production |
| 01/20/2011 | US20110015171 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 01/20/2011 | US20110015170 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 01/20/2011 | US20110015167 Use of norgestimate as a selective inhibitor of trpc3, trpc6 and trpc7 ion channels |
| 01/20/2011 | US20110015165 Modified, hydroxy-substituted aromatic structures having cytoprotective activity |
| 01/20/2011 | US20110015160 Methods of treating neurological diseases using docosahexaenoic acid and arachidonic acid compositions |
| 01/20/2011 | US20110015159 Methods of inhibiting vascular permeability and apoptosis |
| 01/20/2011 | US20110015156 Heterocyclic compounds for the treatment of neurological and psychological disorders |
| 01/20/2011 | US20110015154 Supporting acetylcholine function |
| 01/20/2011 | US20110015145 Cladribine formulations for improved oral and transmucosal delivery |
| 01/20/2011 | US20110015139 Histidine related compounds for identifying and blocking amyloid beta ion channels |
| 01/20/2011 | US20110015132 Synergistic 5'-methylthioadenosine combinations |
| 01/20/2011 | US20110015131 Methods for preventing and treating alzheimer's disease (ad) |
| 01/20/2011 | US20110015129 New paediatric indications for direct thrombin inhibitors |
| 01/20/2011 | US20110014304 Alpha-aminoamide derivatives useful in the treatment of psychiatric disorders |
| 01/20/2011 | US20110014282 Pharmaceutical composition for poorly soluble drugs |
| 01/20/2011 | US20110014279 Bioactive complex compositions and methods of use thereof |
| 01/20/2011 | US20110014270 Prevention and treatment of ischemia-reperfusion injury and related conditions |
| 01/20/2011 | US20110014258 Gradient coating for biomedical applications |
| 01/20/2011 | US20110014251 Microvesicles |
| 01/20/2011 | US20110014243 Pharmaceutical compositions |
| 01/20/2011 | US20110014226 high throughput protein interaction assay |
| 01/20/2011 | US20110014223 Multimeric proteins able to induce an antibody response against the beta-amyloid and use thereof |
| 01/20/2011 | US20110014189 Stable pharmaceutical composition comprising at least one monoclonal antibody and at least one amphiphilic polysaccharide comprising hydrophobic substituents |
| 01/20/2011 | US20110014186 Arylsulfonamide-based matrix metalloprotease inhibitors |
| 01/20/2011 | US20110014183 Mcam modulation and uses thereof |
| 01/20/2011 | US20110014182 Antigen binding proteins |
| 01/20/2011 | US20110014177 Methods for Enhancing Physical and Mental Energy |
| 01/20/2011 | US20110014176 Compounds and method for reducing uric acid |
| 01/20/2011 | US20110014172 Recombinant Human CLN2 Protein and Methods of Its Production and Use |
| 01/20/2011 | US20110014164 Efficient induction of pluripotent stem cells using small molecule compounds |
| 01/20/2011 | US20110014158 Compositions and methods of using chondroitinase abci mutants |
| 01/20/2011 | US20110014132 Solid effervescent mixture for the oral absorption |
| 01/20/2011 | US20110014127 Methods for measuring a patient response upon administration of a drug and compositions thereof |
| 01/20/2011 | US20110014121 Modulators of cxcr7 |
| 01/20/2011 | DE102009033208A1 Aminopyridinderivate Aminopyridine |
| 01/20/2011 | CA2778517A1 Substituted triazole and imidazole derivatives as gamma secretase modulators |
| 01/20/2011 | CA2768377A1 Process for the preparation of o-desmethyl venlafaxine and intermediate for use therein |
| 01/20/2011 | CA2768356A1 Compositions comprising a cholinesterase inhibitor for treating cognitive disorders |
| 01/20/2011 | CA2768342A1 Humic substances and therapeutic uses thereof |
| 01/20/2011 | CA2768329A1 Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction |
| 01/20/2011 | CA2768236A1 (+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof |
| 01/20/2011 | CA2767987A1 Novel carbamate amino acid and peptide prodrugs of opioids and uses thereof |
| 01/20/2011 | CA2767894A1 Apoptosis signal-regulating kinase inhibitors |
| 01/20/2011 | CA2767764A1 Heterocyclic compound and use thereof |